Germany
· Delayed Price · Currency is EUR | Market Cap | 98.97B |
| Revenue (ttm) | 31.58B |
| Net Income (ttm) | 4.05B |
| Shares Out | n/a |
| EPS (ttm) | 3.11 |
| PE Ratio | 24.43 |
| Forward PE | 14.93 |
| Dividend | 2.60 (3.43%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 736 |
| Average Volume | 1,245 |
| Open | 77.37 |
| Previous Close | 78.00 |
| Day's Range | 76.29 - 77.55 |
| 52-Week Range | 70.10 - 90.81 |
| Beta | 0.83 |
| RSI | 56.51 |
| Earnings Date | May 21, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial numbers in USD Financial StatementsNews
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full...
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, ...
Orchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patents Patent estate covering atriov...
Reading Your Brain Waves To Treat a Debilitating Disease
FDA approves Medtronic adaptive deep brain stimulation system for Parkinson's Disease NORTHAMPTON, MA / ACCESS Newswire / May 6, 2025 / Liza Bobrow didn't think it was a big deal when her handwriting ...
Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF
Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized m...
Best Dividend Aristocrats For May 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed...
Medtronic (MDT) Showcases Positive AFib Treatment Results at Key Medical Conference | MDT Stock News
Medtronic (MDT) Showcases Positive AFib Treatment Results at Key Medical Conference | MDT Stock News
Medtronic PLC (MDT) Unveils Promising Clinical Trial Results for Atrial Fibrillation ...
Medtronic PLC (MDT) Unveils Promising Clinical Trial Results for Atrial Fibrillation Technologies | MDT stock news
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...
Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery System
Medtronic PLC (MDT) Achieves Key Milestone with Hugo RAS System in U.S. ...
Medtronic PLC (MDT) Achieves Key Milestone with Hugo RAS System in U.S. Clinical Trial | MDT stock news
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for ...
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo⢠robotic-assisted surgery system | MDT Stock News
Medtronic seeks FDA nod for Hugo robotic surgery system
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Associat...
Medtronic (MDT) Gains FDA Approval for Advanced Defibrillation Lead | MDT Stock News
Medtronic (MDT) Gains FDA Approval for Advanced Defibrillation Lead | MDT Stock News
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the ...
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure⢠lead and announces investigational clinical study results | MDT Stock News
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results
Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: Late-b...
Medtronic seeks FDA nod for insulin pump developed with Abbott
Medtronic (MDT) stock gains as the company seek FDA clearance for an insulin pump exclusively integrating CGM technology developed by Abbott (ABT). Read more here.
Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
GALWAY, Ireland , April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Adm...
Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
FDA recently granted Breakthrough Device Designation to AVIM therapy for use in patients with uncontrolled hypertension at increased cardiovascular risk HRS Satellite Symposium will feature leading ex...
Medtronic: Time To Buy This Dividend Aristocrat Bargain
Grammy Award Winning Artist Knows How Math Can Help Prevent Cancer
Anthony Hamilton experiences how Medtronic is using AI to help detect colon polyps NORTHAMPTON, MA / ACCESS Newswire / April 22, 2025 / Grammy Award winning singer and songwriter Anthony Hamilton unde...
Medtronic: One Of The Best Times To Buy
Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in key segments. Read more about MDT stock here.
Medtronic PLC (MDT) Receives FDA Approval for Simplera Sync⢠Sensor | MDT stock news
Medtronic PLC (MDT) Receives FDA Approval for Simplera Sync⢠Sensor | MDT stock news
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland , April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U....